Acquisition Date:
10/26/2020
Syner-G is a leading provider of CMC technical, regulatory and compliance solutions and services, supporting pharmaceutical and biotechnology companies across small molecule, large molecule, and cell and gene therapy products. Syner-G oversees all aspects of CMC throughout the drug development process and post-commercialization.
10/26/2020
Syner-G is a leading provider of CMC technical, regulatory and compliance solutions and services, supporting pharmaceutical and biotechnology companies across small molecule, large molecule, and cell and gene therapy products. Syner-G oversees all aspects of CMC throughout the drug development process and post-commercialization.
Location: United States, Massachusetts, Southborough
Employees: 51-200
Founded date: 2011
Investors 1
| Date | Name | Website |
| - | Riverside ... | riversidep... |
Mentions in press and media 2
| Date | Title | Description |
| 04.11.2020 | Syner-G Pharma Consulting Receives Investment from Riverside Partners | Riverside Partners completed an investment in Southborough, Mass.-based Syner-G Pharma Consulting, LLC, which provides Chemistry, Manufacturing, and Controls (“CMC”) technical, regulatory and compliance consulting services to pharmaceutical... |
| 29.10.2020 | Riverside Partners Completes Investment in Syner-G | Boston, October 29, 2020 – Riverside Partners, LLC, a Boston-based private equity firm, announced today the completion of an investment in Syner-G Pharma Consulting, LLC (“Syner-G” or the “Company”) in partnership with the Company’s founder... |